<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a member of the nuclear hormone receptor superfamily, is involved in suppressing the growth of several <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We showed that PPAR-gamma is expressed in Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cell lines and inhibited the growth of these lines through the induction of G1 cell cycle arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>We examined PPAR-gamma expression in human esophageal <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> (<z:mp ids='MP_0004207'>SCC</z:mp>) in vitro and in vivo and investigated whether PPAR-gamma ligands affect the proliferation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of human <z:mp ids='MP_0004207'>SCC</z:mp> cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>Biopsy specimens (n=46) obtained from human <z:mp ids='MP_0004207'>SCC</z:mp> of the esophagus were stained using a monoclonal antibody against human PPAR-gamma </plain></SENT>
<SENT sid="4" pm="."><plain>We assessed the effects of PPAR-gamma ligands on the growth of <z:mp ids='MP_0004207'>SCC</z:mp> cells by adding 15-deoxy <z:chebi fb="0" ids="27485">prostaglandin J2</z:chebi> (15d-PGJ2), or <z:chebi fb="0" ids="9753">troglitazone</z:chebi> to six human esophageal <z:mp ids='MP_0004207'>SCC</z:mp> cell lines (TE-1, TE-2, TE-3, TE-5, TE-8, and TE-9) </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemical staining showed that 34 of 46 (73.9%) <z:mp ids='MP_0004207'>SCC</z:mp> of the esophagus expressed PPAR-gamma </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:mp ids='MP_0004207'>SCC</z:mp> cell lines expressed PPAR-gamma <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein, especially when poorly differentiated (TE-2, TE-5, and TE-9) </plain></SENT>
<SENT sid="7" pm="."><plain>The PPAR-gamma ligands significantly and dose-dependently inhibited the proliferation of <z:mp ids='MP_0004207'>SCC</z:mp> lines, except for well-differentiated TE-1 and TE-3 </plain></SENT>
<SENT sid="8" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was induced by 15d-PGJ2 (10 microM) in <z:hpo ids='HP_0000001'>all</z:hpo> tested <z:mp ids='MP_0004207'>SCC</z:mp> lines except TE-1, whereas <z:chebi fb="0" ids="9753">troglitazone</z:chebi> (50 microM) was marginally effective in only the TE-2 and TE-3 cell lines </plain></SENT>
<SENT sid="9" pm="."><plain>The present findings suggest that PPAR-gamma could be a therapeutic target for treating <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> of the esophagus, possibly through the induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>